# US 2026/0062740 A1 · Reducing-agent-free dna polymerase with reduced artifact formation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062740 A1
- Document ID: US20260062740A1
- Status: Published application
- Kind: A1
- Application number: 19/319,451
- Filed: 2025-09-04
- Published: 2026-03-05
- Earliest claimed: 2024-09-04
- Assignees: Promega Corporation
- Applicants: Promega Corporation
- Inventors: David MOKRY; Nicholas A. COURTNEY; Robert S. MCLAREN; Kimberly SCHNELL; Kristopher ZIMMERMAAN
- Web page: https://patentgrep.com/patent/US20260062740A1

## CPC

- C07K 14/47: from mammals
- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C12N 9/1276: {RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase}
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C07K 2319/00: Fusion polypeptide
- C07K 2319/80: containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are compositions and systems comprising a DNA polymerase domain, a thioredoxin binding domain (TBD), and thioredoxin (TRX) engineered to synthesize DNA with reduced stutter artifacts in the absence of a reducing agent. Kits comprising the DNA polymerase/TBD/TRX compositions and systems herein and methods of use thereof in the absence of a reducing agent are also within the scope herein.

## Claims

### Claim 1

A DNA polymerase system comprising:
(a) a DNA polymerase domain;
(b) a thioredoxin binding domain (TBD), wherein the TBD has non-cysteine amino acids at positions corresponding to positions 14 and 52 of SEQ ID NO: 15; and
(c) a thioredoxin (TRX) domain, wherein the TRX domain has a non-cysteine amino acid at a position corresponding to position 35 of SEQ ID NO: 16.

### Claim 2 (depends on 1)

The DNA polymerase system of claim 1, wherein the amino acid at the position corresponding to position 14 of SEQ ID NO: 15 is a leucine.

### Claim 3 (depends on 1)

The DNA polymerase system of claim 1, wherein the amino acid at the position corresponding to position 52 of SEQ ID NO: 15 is a valine.

### Claim 4 (depends on 1)

The DNA polymerase system of claim 1, wherein the amino acid at the position corresponding to position 35 of SEQ ID NO: 16 is a serine.

### Claim 5 (depends on 1)

The DNA polymerase system of claim 1, wherein the TBD has a substitution at a position corresponding to position 66 of SEQ ID NO: 15.

### Claim 6 (depends on 5)

The DNA polymerase system of claim 5, wherein the amino acid at a position corresponding to position 66 of SEQ ID NO: 15 is threonine, valine, or cysteine.

### Claim 7 (depends on 1)

The DNA polymerase system of claim 1, wherein the TRX has a substitution at a position corresponding to position 32 of SEQ ID NO: 16.

### Claim 8 (depends on 7)

The DNA polymerase system of claim 7, wherein the amino acid at a position corresponding to position 32 of SEQ ID NO: 16 is alanine, cysteine, aspartic acid, glycine, proline, or serine.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the DNA polymerase system is capable of synthesizing a DNA product from deoxynucleoside triphosphates in the presence of a DNA template and under appropriate reaction conditions.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the DNA polymerase system exhibits reduced stutter proclivity compared to a DNA polymerase comprising the DNA polymerase domain in the absence of the TBD and/or TRX.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the DNA polymerase system exhibits at least 2-fold reduced stutter proclivity compared to a DNA polymerase comprising the DNA polymerase domain in the absence of the TBD and/or TRX.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the DNA polymerase system comprises the DNA polymerase domain conjugated to the TBD and/or TRX.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the DNA polymerase system comprises the DNA polymerase domain genetically fused to the TBD and/or TRX.

### Claim 14 (depends on 13)

The composition of claim 13, wherein the DNA polymerase system comprises a genetic fusion of the DNA polymerase domain, TBD, and TRX.

### Claim 15 (depends on 1)

The composition of claim 1, wherein one or more of the DNA polymerase domain, TBD, and TRX are not conjugated to the other components of the system.

### Claim 16 (depends on 15)

The composition of claim 15, comprising a free TRX and a DNA polymerase domain conjugated or genetically fused to a TBD.

### Claim 17 (depends on 15)

The composition of claim 15, comprising a free TBD and a DNA polymerase domain conjugated or genetically fused to a TRX.

### Claim 18 (depends on 15)

The composition of claim 15, comprising a free DNA polymerase domain and a TRX conjugated or genetically fused to a TBD.

### Claim 19 (depends on 15)

The composition of claim 15, comprising a DNA polymerase domain, TRX, and TBD conjugated or genetically fused together.

### Claim at position 20

20-130. (canceled)

### Claim 131 (depends on 1)

A method of amplifying a DNA target sequence comprising exposing the composition of claim 1 to amplification reagents sufficient to amplify a DNA target sequence and polymerase chain reaction thermal cycling conditions.

### Claim at position 22

132-159. (canceled)
